Characteristics and outcome of SARS-CoV-2 infection in cancer patients
Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat, Sandra Malak, François-Clément Bidard, Dominique Vanjak, Irène Kriegel, Alexis Burnod, Geoffroy Bilger, Toulsie Ramtohul, Gilles Dhonneur, Carole Bouleuc, Nathalie Cassoux, Institut Curie COVID Group, Xavier Paoletti, Laurence Bozec, Paul Cottu
doi: https://doi.org/10.1101/2020.05.14.20101576
Clémence Basse
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDSarah Diakite
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDVincent Servois
2Department of Radiology, Institut Curie, Paris, France
MDMaxime Frelaut
3Department of Drug Development and Innovation, Institut Curie, Paris & Saint Cloud, France
MDAurélien Noret
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDAudrey Bellesoeur
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDPauline Moreau
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDMarie-Ange Massiani
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDAnne-Sophie Bouyer
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDPerrine Vuagnat
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
4UVSQ, Université Paris-Saclay, Saint Cloud, France
MDSandra Malak
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDFrançois-Clément Bidard
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
4UVSQ, Université Paris-Saclay, Saint Cloud, France
MD, PhDDominique Vanjak
5Infectious Diseases Unit, Institut Curie, Paris & Saint Cloud, France
MDIrène Kriegel
6Department of Anesthesia, Intensive Care and Pain Medicine, Institut Curie, Paris & Saint Cloud, France
MDAlexis Burnod
7Supportive and Palliative Care Department, Institut Curie, Paris & Saint-Cloud, France
MDGeoffroy Bilger
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDToulsie Ramtohul
2Department of Radiology, Institut Curie, Paris, France
Gilles Dhonneur
6Department of Anesthesia, Intensive Care and Pain Medicine, Institut Curie, Paris & Saint Cloud, France
MD, PhDCarole Bouleuc
7Supportive and Palliative Care Department, Institut Curie, Paris & Saint-Cloud, France
MDNathalie Cassoux
8Department of Surgical Oncology, Institut Curie, Paris & Saint-Cloud, France
9Université de Paris, Paris, France
MD, PhDXavier Paoletti
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
4UVSQ, Université Paris-Saclay, Saint Cloud, France
MD, PhDLaurence Bozec
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDPaul Cottu
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD, PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted May 19, 2020.
Characteristics and outcome of SARS-CoV-2 infection in cancer patients
Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat, Sandra Malak, François-Clément Bidard, Dominique Vanjak, Irène Kriegel, Alexis Burnod, Geoffroy Bilger, Toulsie Ramtohul, Gilles Dhonneur, Carole Bouleuc, Nathalie Cassoux, Institut Curie COVID Group, Xavier Paoletti, Laurence Bozec, Paul Cottu
medRxiv 2020.05.14.20101576; doi: https://doi.org/10.1101/2020.05.14.20101576
Characteristics and outcome of SARS-CoV-2 infection in cancer patients
Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat, Sandra Malak, François-Clément Bidard, Dominique Vanjak, Irène Kriegel, Alexis Burnod, Geoffroy Bilger, Toulsie Ramtohul, Gilles Dhonneur, Carole Bouleuc, Nathalie Cassoux, Institut Curie COVID Group, Xavier Paoletti, Laurence Bozec, Paul Cottu
medRxiv 2020.05.14.20101576; doi: https://doi.org/10.1101/2020.05.14.20101576
Subject Area
Subject Areas
- Addiction Medicine (329)
- Allergy and Immunology (650)
- Anesthesia (174)
- Cardiovascular Medicine (2502)
- Dermatology (210)
- Emergency Medicine (385)
- Epidemiology (11977)
- Forensic Medicine (10)
- Gastroenterology (718)
- Genetic and Genomic Medicine (3900)
- Geriatric Medicine (362)
- Health Economics (653)
- Health Informatics (2515)
- Health Policy (973)
- Hematology (350)
- HIV/AIDS (813)
- Medical Education (386)
- Medical Ethics (106)
- Nephrology (416)
- Neurology (3656)
- Nursing (205)
- Nutrition (544)
- Oncology (1901)
- Ophthalmology (554)
- Orthopedics (230)
- Otolaryngology (299)
- Pain Medicine (243)
- Palliative Medicine (71)
- Pathology (461)
- Pediatrics (1071)
- Primary Care Research (434)
- Public and Global Health (6327)
- Radiology and Imaging (1340)
- Respiratory Medicine (845)
- Rheumatology (389)
- Sports Medicine (334)
- Surgery (426)
- Toxicology (51)
- Transplantation (179)
- Urology (155)